Press release
Continuous Glucose Monitoring Devices Market Surges with Rising Diabetes Prevalence and Technological Upgrades, 2025-2032
Continuous Glucose Monitoring Devices Market is estimated to be valued at USD 7.81 Bn in 2025 and is expected to reach USD 15.12 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032. The global continuous glucose monitoring (CGM) devices market is experiencing significant growth, fueled by the rising demand for real-time glucose monitoring and the increasing global prevalence of diabetes. The market is further driven by the adoption of advanced CGM technologies and the expanding geriatric population worldwide. However, the high cost of CGM devices and inadequate reimbursement policies remain key challenges that could restrain market growth.Get Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/57
➤Actionable Insights
● Production capacity of continuous glucose monitoring devices rose by 18% in 2024, fueled by expansions in manufacturing hubs across Asia-Pacific and North America.
● Average selling prices moderated by 3.5% in 2024 due to technological optimizations and economies of scale, making devices more accessible to a broader patient base.
● Import data indicates a 21% surge in device shipments to emerging markets like India and Brazil in 2024, highlighting growing demand beyond traditional high-income countries.
● Use cases have diversified as CGM devices are increasingly integrated in hospital intensive care units and outpatient diabetes management programs, reflecting broader clinical acceptance.
● Micro-level indicators show that wearable CGM sensors with enhanced biocompatibility achieved a 27% market penetration among type 1 diabetes patients in Europe by mid-2024.
❖Market Segment and Regional Coverage
○ By Device Type: Real-Time CGM Devices, Intermittently Scanned CGM Devices, Professional CGM Devices, Implantable CGM Devices, and Others.
○ By End User: Hospitals, Home Care Settings, Ambulatory Care Centers, and Clinics.
○ By Application: Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, and Others.
Regional and Country Analysis:
○ North America: U.S. and Canada
○ Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
○ Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
○ Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
○ Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/57
✔Key players
» Dexcom Inc., Abbott Laboratories, Medtronic plc, Senseonics Holdings, Inc., Roche Diabetes Care, Ascensia Diabetes Care, Tandem Diabetes Care, AgaMatrix, Inc., IRIS International Inc., Nemaura Medical Inc., Becton Dickinson and Company, and Ypsomed AG.
» Dexcom and Abbott have notably pursued aggressive go-to-market strategies by expanding partnerships with healthcare providers, resulting in a combined 15% uptick in market penetration in 2024.
» Medtronic focused on enhancing device interoperability with smartphone platforms, which increased user retention and contributed to a 12% uplift in device usage in hospital settings during 2024.
➤Growth factors
✓ Increasing prevalence of diabetes worldwide, with WHO citing over 540 million adults expected to be diabetic by 2025, driving sustained demand for CGM devices.
✓ Technological advancements such as longer sensor wear-time and improved accuracy have reduced patient discomfort and device calibrations, encouraging adoption.
✓ Growing insurance reimbursements and healthcare policies supporting remote patient monitoring have expanded accessibility, especially in North America and Europe.
✓ Collaborative initiatives between device makers and digital health firms are accelerating integration of CGM data into telemedicine platforms, improving personalized diabetes management outcomes.
❖ Market trends
⇨ Shift towards non-invasive and implantable continuous glucose monitoring devices is gaining momentum, with at least 3 new devices receiving regulatory approvals in 2024, improving patient compliance.
⇨ Artificial intelligence (AI)-driven predictive analytics integrated with CGM devices enable proactive detection of hypo- and hyperglycemic events, demonstrated in pilot programs involving over 10,000 patients globally in 2024.
⇨ Emerging markets are witnessing rapid growth due to government health initiatives aimed at increasing diabetes awareness, with regional capacities rising by 25% in APAC in 2024.
⇨ Integration of CGM devices with insulin pumps and closed-loop systems is evolving the landscape of automated diabetes care, with revenue from such hybrid systems expected to grow at a CAGR of 14% through 2032.
✒Key takeaways
→ Device types: Real-time CGM dominates with growing implantable CGM adoption due to enhanced patient comfort and device longevity.
→ End users: Home care settings show fastest growth driven by wearables and remote monitoring capabilities.
→ Applications: Type 1 diabetes remains the largest segment, supported by continuous innovation in sensor accuracy and user interface.
→ Regions: North America leads innovation and reimbursement frameworks facilitating market growth; Asia-Pacific presents significant expansion opportunities fueled by rising diabetic populations and improved healthcare infrastructure.
→ Europe shows stable demand with emphasis on integrated digital health solutions; Latin America is gaining traction with increased governmental focus on chronic disease management.
→ Market dynamics are increasingly influenced by cross-sector collaborations involving digital health and AI, accentuating the scope for business growth and new market opportunities in the Continuous Glucose Monitoring Devices market.
To Purchase This Premium Report, Click Here (Discount of Up to 25%): https://www.coherentmarketinsights.com/insight/buy-now/57
❓ Frequently Asked Questions
1. Who are the dominant players in the Continuous Glucose Monitoring Devices market?
The market is led by established companies such as Dexcom Inc., Abbott Laboratories, and Medtronic plc, which have implemented innovative strategies including product enhancement and strategic partnerships to increase market share.
2. What will be the size of the Continuous Glucose Monitoring Devices market in the coming years?
The market size is projected to grow from USD 7.4 billion in 2025 to USD 15.6 billion by 2032, reflecting a robust CAGR of 11.2%, driven by adoption across various diabetes segments and regions.
3. Which end user industry has the largest growth opportunity?
Home care settings are experiencing the fastest growth, largely due to improved wearable device usability, remote monitoring technologies, and wider reimbursement policies supporting outpatient diabetes care.
4. How will market development trends evolve over the next five years?
Trends point towards increased adoption of non-invasive CGM, AI integration for predictive analytics, and expanded presence in emerging economies facilitated by healthcare digitalization and supportive policies.
5. What is the nature of the competitive landscape and challenges in the Continuous Glucose Monitoring Devices market?
The landscape is marked by intense innovation-focused competition with challenges including regulatory compliance, cost pressures, and evolving reimbursement scenarios that players address through diversification and strategic collaborations.
Author of this Marketing PR:
Ravina Pandya, PR Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837
About CMI:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Continuous Glucose Monitoring Devices Market Surges with Rising Diabetes Prevalence and Technological Upgrades, 2025-2032 here
News-ID: 4104895 • Views: …
More Releases from Coherent Market Insights Pvt. Ltd.

Pneumococcal Vaccines Market is evolving rapidly Through 2025 To 2032 | Pfizer I …
The pneumococcal vaccines market is a critical component of global public health initiatives aimed at combating Streptococcus pneumoniae infections, which cause severe illnesses such as pneumonia, meningitis, and septicemia. Advances in vaccine technology and increasing awareness about pneumococcal diseases have contributed to the industry's steady expansion. Healthcare infrastructure enhancements and government immunization programs worldwide further support the uptake of pneumococcal vaccines across various age groups. The Global Pneumococcal Vaccines Market…

Point Of Care Diagnostics Market Set to Soar by 2032 with Emerging Innovations a …
The Point Of Care Diagnostics industry continues to gain significant traction as rapid and accurate diagnostic solutions become increasingly critical across healthcare settings worldwide. Innovations in portable and easy-to-use devices that enable testing near the patient have driven broader adoption, fostering improvements in clinical outcomes and operational efficiency. The industry's capacity to reduce diagnosis time and facilitate immediate clinical decision-making is reshaping healthcare delivery, particularly in emergency care, chronic disease…
![Alzheimers Drugs Market [2025-2032] - Exclusive Report Featuring In-Depth Analysis and Leading Key Players AbbVie, Inc., Teva Pharmaceuticals Ltd.](https://cdn.open-pr.com/L/7/L725849991_g.jpg)
Alzheimers Drugs Market [2025-2032] - Exclusive Report Featuring In-Depth Analys …
The Alzheimer's Drugs Market is witnessing transformative growth driven by ongoing advancements in pharmaceutical research and an increasing global aging population. As life expectancy rises, the incidence of Alzheimer's disease is escalating, necessitating innovative drug development and diversified treatment options. This evolving landscape is marked by intensive clinical trials and expanding therapeutic pipelines. The Global Alzheimer's Drugs Market size is estimated to be valued at USD 5.64 Billion in 2025…

Electronic Health Records Market Booming Amid Surge in Digital Healthcare Adopti …
The Electronic Health Records (EHR) industry continues to reshape healthcare delivery by enabling seamless patient data management and enhancing clinical workflows. Over the past few years, integration of advanced technologies such as AI and cloud computing has accelerated the adoption of EHR systems, driving considerable innovation across healthcare providers and payers. The market's increasing role in streamlining healthcare services, reducing medical errors, and enabling regulatory compliance underscores its strategic importance…
More Releases for CGM
Universal Adhesive Patch For CGM And Insulin Pump
Universal adhesive patch for CGM and insulin pump, waterproof breathable transparent patch, pre-cut tape, CGM protection, skin-friendly patch for 10-14 days
Waterproof & Reinforced Defense - Pair it with your CGM Blood Glucose Monitoring Sensor [https://www.uwtapes.com/uw-adhesive-patch/] or TruSteel Infusion Kit while showering, bathing, exercising or swimming without worry. Protect your CGM sensor from collisions.
Compatible with CGM sensors and insulin pumps [https://www.uwtapes.com/uw-adhesive-patch/] - ideal for users of closed loop systems. Suitable for…
Global BGM and CGM Market Research Report 2023-2029
Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose. Continuous glucose monitoring automatically tracks blood glucose levels,…
Continuous Glucose Monitoring (CGM) Devices Market Higher convenience offered by …
The CGM displays a glucose trend graph and direction arrows allowing people with diabetes to anticipate approaching glucose highs and lows, thus alerting the wearer during distracted times like playing, sleeping or exercising. The CGM devices market is expected to gain a significant traction in Asia Pacific owing to the collaborations between endocrinologists, credentialed diabetes educators and stakeholder organizations for diabetes prevention.
In 2017, National Diabetes Services Scheme (NDSS) initiated by…
Global Continuous Glucose Monitoring Devices (CGM) Market
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Continuous Glucose Monitoring Device Market. The report analyzes the Global Continuous Glucose Monitoring Market by Component (Transmitter & receiver, sensor, Integrated Insulin Pump), By Demographics (Pediatric, Adult), By End user (Homecare, Hospital), By Region (North America, Europe, Asia Pacific, Rest of the world)…
CMA CGM S. A. - Company Strategy & Performance Analysis
The research report presents a comprehensive assessment of the CMA CGM S. A. and contains thoughtful insights, facts, historical data, and statistically supported and industry validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and deal landscapes.
Purchase the Report at (USD $499 only): https://www.marketinsightsreports.com/report/purchase/0926871550?mode=su?source=openpr&Mode=12
CMA CGM…
Global Continuous Glucose Monitoring (CGM) Market,
The Global Continuous Glucose Monitoring Market (CGM) was valued at US$ 444.0 million in 2015 and is projected to reach US$ 1,025.2 million by 2024, according to a new report by published by Coherent Market Insights. CGM devices allow monitoring of glucose level during bedtime, noon, pre/post lunch, or before/after exercise, which is a major factor propelling growth of the continuous glucose monitoring market.
The global CGM market is undergoing a…